Výsledky vyhledávání - "I. Spadinger"

Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer

Autor: I. Spadinger, Tom Pickles, Howard Pai, M. Liu, W. James Morris, Michael McKenzie, Winkle Kwan, Mira Keyes, Scott Tyldesley

Publikováno v: Cancer. 119:1537-1546

BACKGROUND. The objective of this study was to report the rates of disease-free survival (DFS), cause-specific survival (CSS), and overall survival after low-dose-rate (LDR) prostate brachytherapy (PB). METHODS. Data from 1006 consecutive patients wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b932b5839a96f3eab796887112d795f5
https://doi.org/10.1002/cncr.27911

Zobrazit plný text záznamu

Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy

Autor: Mira Keyes, W. James Morris, I. Spadinger, Jackson Chu, Tom Pickles, Jeremy Hamm, Maryam Golshan

Publikováno v: Brachytherapy. 14(3)

Purpose/objectives To assess regional dose metrics as predictors of disease relapse after low-dose-rate prostate brachytherapy. Methods and Materials A cohort of 2000 consecutive patients with prostate cancer treated with iodine-125 low-dose-rate pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289b80e22c1861cf7adafe9c11117f1f
https://pubmed.ncbi.nlm.nih.gov/25638507

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival

Autor: Andrea Lo, Mira Keyes, Michael McKenzie, W. James Morris, Jeremy Hamm, Tom Pickles, I. Spadinger, Vincent Lapointe

Publikováno v: International journal of radiation oncology, biology, physics. 88(1)

To determine (1) the prognostic utility of prostate-specific antigen (PSA) concentration at 45 to 60 months (48mPSA) after low-dose-rate prostate brachytherapy (LDR-PB); (2) the predictors of 48mPSA; and (3) the prognostic utility of directional tren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4892733c821f245941133b9feed6c4d4
https://pubmed.ncbi.nlm.nih.gov/24331654

Zobrazit plný text záznamu

Prostate brachytherapy postimplant dosimetry: automatic plan reconstruction of stranded implants

Autor: N, Chng, I, Spadinger, W J, Morris, N, Usmani, S, Salcudean

Publikováno v: Medical physics. 38(1)

Plan reconstruction for permanent implant prostate brachytherapy is the process of determining the correspondence between planned and implanted seeds in postimplant analysis. Plan reconstruction informs many areas of brachytherapy quality assurance,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e7cde8a97d23f82a542b263d0b99a256
https://pubmed.ncbi.nlm.nih.gov/21361201

Zobrazit plný text záznamu

Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (∼2 Gy) doses in hypoxic cells:I. Role of single-strand breaks

Autor: Kirsten A. Skov, P. Walter, I. Spadinger, M. Korbelik

Publikováno v: Radiation Oncology Investigations. 1:137-147

There is a need for radiosensitizers, to be used in conjunction with fractionated radiotherapy (∼2 Gy), because of the resistance of the hypoxic portions of tumors. A marked selective interaction between cisplatin (cis-diamminedichloroplatinum (II)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ac3beab3611554e723b3b22a0595057
https://doi.org/10.1002/roi.2970010303

Zobrazit plný text záznamu

Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer

Autor: Mira Keyes, H. Pai, D. Palma, W.J. Morris, I. Spadinger, M.R. McKenzie, Alexander Agranovich, Winkle Kwan, E. Berthelet, Tom Pickles, Jonn Wu, Mitchell Liu

Publikováno v: Urology. 73(4)

To analyze the biochemical and survival outcomes after permanent low-dose-rate prostate brachytherapy in a large, consecutive, population-based cohort of patients.A total of 1006 consecutive implants were performed from July 20, 1998 to October 23, 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3f79581972362f3440ddcc2ad575c3
https://pubmed.ncbi.nlm.nih.gov/19168203

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání